XSHG
688133
, Last price
Name
Shanghai Titan Scientific Co Ltd
Chart & performance
P/E
—
P/S
—
EPS
—
Vol. 1Y
—
Shs. 5Y
6.59%
Rev. 5Y
12.68%
Div Yld LY
—
Div Yld TTM
—
Revenues
2.51b
-12.79%
Net income
-31m
L
CFO
238m
+26.18%
Dividend
Jun 20, 20250.07 /sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Shanghai Titan Scientific Co., Ltd. furnishes essential laboratory supplies and comprehensive support services tailored for scientists and quality assurance professionals. The company caters to diverse laboratory domains such as biomedical research, advanced materials, renewable energy, industrial chemistry, specialty chemicals, consumer product manufacturing, and analytical testing. It achieves this through a multifaceted approach, including proprietary product development, brand stewardship, strategic distribution agreements, and all-inclusive service packages. Founded in 2007, the company's main operations are based in Shanghai, China.
IPO date
Oct 30, 2020
Employees
Domiciled in
CN
Incorporated in
CN
Headquarters & legal address
上海市徐汇区钦州路100号一号楼1110室
徐汇区, SH 200000
CN
徐汇区, SH 200000
CN
Other language
Shanghai Titan Technology Co., Ltd
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||